Resistance to BRAF inhibition in melanoma: An epigenetic approach

被引：0
|
作者：
Walston, Steve
Gordon, Nicolaus
Chakravarti, Arnab
Palanichamy, Kamalakannan
机构：
[1] Ohio State Univ, Ctr Comprehens Canc, Med Ctr, Columbus, OH 43210 USA
[2] Ohio State Univ, Arthur G James Canc Ctr, Columbus, OH 43210 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19040
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanoma
    Wang, Beike
    Zhang, Wei
    Zhang, Gao
    Kwong, Lawrence
    Lu, Hezhe
    Tan, Jiufeng
    Sadek, Norah
    Xiao, Min
    Zhang, Jie
    Labrie, Marilyne
    Randell, Sergio
    Beroard, Aurelie
    Sugarman, Eric
    Rebecca, Vito W.
    Wei, Zhi
    Lu, Yiling
    Mills, Gordon B.
    Field, Jeffrey
    Villanueva, Jessie
    Xu, Xiaowei
    Herlyn, Meenhard
    Guo, Wei
    [J]. ONCOGENE, 2021, 40 (37) : 5590 - 5599
  • [32] HGF mediated resistance to BRAF inhibition in BRAF V600E mutant melanoma xenograft models
    Cooke, Keegan
    Huang, Guo
    Caenepeel, Sean
    Ma, Hong
    Plewa, Cherylene
    Lee, Ki Jeong
    Coxon, Angela
    Hughes, Paul E.
    Beltran, Pedro
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [33] BRAF/MEK inhibition in melanoma patients with rare BRAF mutations
    Hassel, Jessica Cecile
    Menzer, Christian
    Menzies, Alexander M.
    Carlino, Matteo S.
    Long, Georgina V.
    Kefford, Richard
    Eigentler, Thomas K.
    Johnson, Douglas Buckner
    Schlaak, Max
    Meiss, Frank
    Schilling, Bastian
    Gutzmer, Ralf
    Pfoehler, Claudia
    Meier, Friedegund Elke
    Zimmer, Lisa
    Haalck, Thomas
    Thoms, Kai
    Kopp-Schneider, Annette
    Enk, Alexander
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [34] Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanoma
    Beike Wang
    Wei Zhang
    Gao Zhang
    Lawrence Kwong
    Hezhe Lu
    Jiufeng Tan
    Norah Sadek
    Min Xiao
    Jie Zhang
    Marilyne Labrie
    Sergio Randell
    Aurelie Beroard
    Eric Sugarman
    Vito W. Rebecca
    Zhi Wei
    Yiling Lu
    Gordon B. Mills
    Jeffrey Field
    Jessie Villanueva
    Xiaowei Xu
    Meenhard Herlyn
    Wei Guo
    [J]. Oncogene, 2021, 40 : 5590 - 5599
  • [35] Effects of BRAF Mutations and BRAF Inhibition on Immune Responses to Melanoma
    Ilieva, Kristina M.
    Correa, Isabel
    Josephs, Debra H.
    Karagiannis, Panagiotis
    Egbuniwe, Isioma U.
    Cafferkey, Michiala J.
    Spicer, James F.
    Harries, Mark
    Nestle, Frank O.
    Lacy, Katie E.
    Karagiannis, Sophia N.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2014, 13 (12) : 2769 - 2783
  • [36] BRAF inhibition and cytokine therapy for melanoma: A novel rational combined approach.
    Romano, Gabriele
    Liang, Roger
    Liu, Mingguang
    Miller, John
    Costello, James
    Kwong, Lawrence
    [J]. CANCER RESEARCH, 2018, 78 (10) : 58 - 58
  • [37] Overcoming BRAF Inhibitor Resistance in Melanoma
    Smalley, Keiran
    Fedorenko, Inna
    Paraiso, Kim H.
    Flach, Edward
    Anderson, Alexander R.
    [J]. JOURNAL OF IMMUNOTHERAPY, 2010, 33 (08) : 910 - 910
  • [38] Response and resistance to BRAF inhibitors in melanoma
    Flaherty, K. T.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : 14 - 14
  • [39] OVERCOMING BRAF INHIBITOR RESISTANCE IN MELANOMA
    Chan, Xian Yang
    Brassington, Kurt
    Darby, Ian A.
    Piva, Terrence J.
    [J]. WOUND REPAIR AND REGENERATION, 2016, 24 (06) : A26 - A26
  • [40] Resistance to BRAF Inhibition in Melanomas
    Solit, David B.
    Rosen, Neal
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (08): : 772 - 774
12345